INTRODUCTION {#S1}
============

Lineage specification in the mouse embryo during gastrulation generates progressively more restricted precursors from initially uncommitted postimplantation epiblast cells ([@R76]). Cell fate restriction is spatially organised ([@R49]) by localised signalling cues and is reflected by the regionalised expression of lineage-specific markers ([@R61]; [@R2]; [@R74]). However, pluripotency is widespread in the epiblast until around the start of somitogenesis ([@R60]). A defining feature of gastrulation is the formation of the primitive streak (PS), a posterior structure in which epiblast cells undergo epithelial-to-mesenchymal (EMT) transition, ingressing to give rise initially to the endoderm and mesoderm of the head and heart, and later to progressively more posterior mesoderm types, including somites ([@R42]; [@R43]). Anterior epiblast that does not encounter the PS instead forms ectoderm-restricted lineages, including the anterior neural ectoderm ([@R48]; [@R14]). Clonal analysis showed that some early-ingressing mesodermal derivatives arise from a common mesendodermal (ME) precursor, whereas later-ingressing somitic mesoderm is generated by a neuromesodermal (NM) progenitor, which also gives rise to the neurectoderm of the spinal cord ([@R76]).

One of the earliest markers for the PS is the T-box transcription factor *T*(*Bra*), which is expressed both in pre-EMT prospective mesoderm and endoderm in the posterior epiblast, and in post-EMT, nascent mesoderm in the PS and its descendant, the tail bud ([@R78]; [@R44]; [@R64]; [@R13]). *T*(*Bra*) is also expressed in the node and notochord. Wnt and Nodal signalling are essential for both PS specification ([@R52]; [@R8]) and the initiation of T(Bra) expression ([@R21]; [@R3]).

Despite considerable progress in defining the role of the interactions between signalling pathways and regionalised genetic activity in the induction of PS precursors, the inaccessibility of mouse embryos renders the study of the transition from pluripotency to lineage restriction difficult. Epiblast stem cells (EpiSCs), cell lines derived from the postimplantation epiblast ([@R12]; [@R75]) or from embryonic stem cells (ESCs) *in vitro* ([@R33]), represent an attractive model for dissecting early lineage commitment as they comprise the *in vitro* counterpart of pluripotent cells in the gastrula stage epiblast ([@R37]). Unlike mouse ESCs but similar to human ES cells (hESCs), self-renewal of EpiSCs, reflected by the simultaneous expression of the key pluripotency factors *Oct4* (*Pou5f1* - Mouse Genome Informatics), *Nanog* and *Sox2*, relies on culture in the mesoderm inducers Activin (inhibin - Mouse Genome Informatics), a Nodal-like TGFβ family member, and Fgf2 ([@R75]; [@R77]; [@R31]). Like the gastrulating epiblast ([@R61]; [@R2]), EpiSC lines also express, under self-renewing conditions, lineage-specific markers ([@R75]; [@R9]; [@R74]; [@R39]; [@R45]). Variations in their expression at the population level have been shown to result in altered differentiation outcome ([@R9]). However, whether heterogeneous lineage-specific marker expression is an inherent feature of EpiSC pluripotency, reflecting the emergence of pioneer lineage-biased yet uncommitted precursors, or a manifestation of commitment to specific lineages induced by culture conditions is presently unknown.

Here we dissect the events underlying the progressive commitment of pluripotent EpiSCs to PS-derived lineages. Using a T(Bra)-based, PS-specific fluorescent reporter, we characterise a major self-renewing fraction of undifferentiated EpiSCs that exhibits early gastrulation, pre-ingression (i.e. epiblast-like) PS characteristics and readily interconverts with reporter-negative cells. PS-like EpiSCs are dependent on endogenous Wnt signalling and are biased towards mesodermal and endodermal differentiation with retention of pluripotency. Further elevation of Wnt activity drives cells out of pluripotency, producing two mutually exclusive cell types resembling ME and NM progenitors present in the PS *in vivo*. Collectively, our findings suggest that, *in vivo*, regional gene expression defines cells in the gastrulation stage epiblast that are biased towards, but not committed to, distinct differentiation outcomes.

RESULTS {#S2}
=======

Two major subpopulations in EpiSC cultures reflecting PS and neurectoderm {#S3}
-------------------------------------------------------------------------

Previous studies have reported the expression of lineage-specific markers in self-renewing EpiSC populations ([@R75]; [@R9]; [@R45]). We sought to extend these findings at the single cell level. Immunocytochemistry revealed that the early PS marker T(Bra) ([@R64]) is expressed heterogeneously in undifferentiated EpiSCs irrespective of whether they were derived from ESCs *in vitro* or from the postimplantation epiblast ([Fig. 1A](#F1){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S1). Image analysis showed that many T(Bra)^+^ cells co-expressed the main pluripotency markers: epiblast-specific Oct4 and Nanog, and epiblast/neural marker Sox2 ([Fig. 1A](#F1){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S1). We also observed some colocalisation between Nanog and the endoderm/organiser/axial mesoderm marker Foxa2 ([@R66]) ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S1A). Collectively, these data indicate that EpiSCs, marked by Oct4, Nanog and Sox2 expression, heterogeneously express PS markers, suggesting that PS-like subpopulations are not products of spontaneous differentiation.

![**Undifferentiated EpiSCs contain two major subpopulations.** (A) Nanog and T(Bra) immunocytochemistry in undifferentiated, wild-type EpiSCs. Graph: immunofluorescence quantitation following single cell image analysis. Numbers: percentages of cells in each quadrant. (B) dsRed2 expression in undifferentiated Tps/tb-RED EpiSCs assessed by fluorescence microscopy (left) and flow cytometry (right). (C) qPCR for indicated markers in sorted dsRed2^+^ and dsRed2^-^ Tps/tb-RED EpiSCs. Results are represented as log~10~ ratio of expression versus dsRed2^-^ cells (left) (^\*^*P*\<0.05, Student's *t*-test) or dissected E8.5 PS (right). Error bars: s.e.m. (*n*=3). (D) Left, fluorescence analysis of dsRed2, T(Bra) and Foxa2 expression in Tps/tb-RED EpiSCs. Right, quantitation of T(Bra) and Foxa2 positivity in dsRed2^+^ and dsRed2^-^ populations after immunostaining of Tps/tb-RED EpiSCs and image analysis. T, T(Bra); F, Foxa2. Error bars: s.e.m. (*n*=3), ^\*^*P*\<0.05 (chi-squared test). (E) Nes immunocytochemistry and dsRed2 fluorescence. Arrowheads: dsRed2^+^ cells. (F) Cdh2 immunocytochemistry and dsRed2 fluorescence. Asterisks, Cdh2^high^ cells; arrowheads, dsRed2^+^/Cdh2^low^ cells. (G) Top: GFP and T(Bra) immunocytochemistry in Sox1-GFP EpiSCs. Bottom left: quantification of T(Bra) and Sox1-GFP expression domains. Bottom right: fluorescence-activated cell sorting (FACS) analysis of GFP expression in self-renewing Sox1-GFP EpiSC cultures. (H) qPCR analysis of neural and early PS marker expression in sorted Sox1-GFP ^+^ and Sox1-GFP^-^ EpiSCs. Results are represented as log (GFP^+^/GFP^-^ cell) values. Error bars: s.e.m. (*n*=3), ^\*^*P*\<0.05 (Student's *t*-test). BF, Brightfield.](DEV101014F1){#F1}

To further characterise EpiSC heterogeneity, we established a PS reporter EpiSC line (Tps/tb-RED), which showed a characteristic EpiSC expression profile and dependence on Activin signalling ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S2). We used a dsRed2 transgene under the transcriptional control of a randomly integrated *T*(*Bra*) promoter fragment (Tps/tb) shown to be active specifically in the PS and the tail bud but not the notochord ([@R20]; [@R80]). Analysis of E8.5 chimeric embryos following blastocyst injection of Tps/tb-RED ESCs confirmed dsRed2 expression specifically in the PS and nascent paraxial mesoderm ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S2). Furthermore, Tps/tb promoter activity was already detectable by the onset of gastrulation in the PS of E6.5 chimeras ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S3).

In EpiSC conditions, we found that a prominent fraction of Tps/tb-RED EpiSCs (15-30%) expressed dsRed2 ([Fig. 1B](#F1){ref-type="fig"}). Quantitative PCR (qPCR) analysis of flow cytometry-sorted dsRed2^+^ and dsRed2^-^ EpiSC populations revealed that dsRed2^+^ cells were enriched for early PS and organiser markers ([Fig. 1C](#F1){ref-type="fig"}), whereas expression of neural-related genes was more pronounced in the dsRed2^-^ fraction ([Fig. 1C](#F1){ref-type="fig"}). Expression of late PS markers, activated at the end of gastrulation (*Wnt3a, Cdx4* and *Nkx1-2*) ([@R28]; [@R72]; [@R67]), as well as the differentiated somitic mesoderm marker *Meox1* ([@R16]) was low in both populations ([Fig. 1C](#F1){ref-type="fig"}). At the protein level, dsRed2 positivity predominantly marked T(Bra)^+^ cells that were either Foxa2^+^ or Foxa2^-^ ([Fig. 1D](#F1){ref-type="fig"}). By contrast, most dsRed2^-^ cells were negative for both T(Bra) and Foxa2, although about 20% expressed Foxa2 but not T(Bra) ([Fig. 1D](#F1){ref-type="fig"}). Only a few dsRed2^+^ cells co-expressed the neural markers nestin (Nes) ([@R51]) and Cdh2 ([@R62]) ([Fig. 1E,F](#F1){ref-type="fig"}). Taken together, these data suggest that under conditions promoting an undifferentiated state, heterogeneous expression of the Tps/tb promoter-driven dsRed2 reporter marks an EpiSC fraction enriched in early PS-like cells.

The depletion of neural markers in dsRed2^+^ cells prompted us to investigate whether the dsRed2^-^ population includes neural-like cells. To this end, an EpiSC line was established from 46C ESCs that carry a GFP reporter within the neurectoderm-specific *Sox1* locus ([@R79]; [@R81]). Analysis of Sox1-GFP EpiSCs by flow cytometry showed that ∼20-25% of cells were GFP^+^ ([Fig. 1G](#F1){ref-type="fig"}). These were found by immunostaining to express very low or no T(Bra) protein ([Fig. 1G](#F1){ref-type="fig"}). Flow sorted Sox1-GFP^+^ cells were significantly enriched for neural-specific transcripts such as *Sox1* itself and, to a lesser extent, *Pax6* ([@R32]) ([Fig. 1H](#F1){ref-type="fig"}) while expressing lower levels of early PS markers than their negative counterparts ([Fig. 1H](#F1){ref-type="fig"}), in line with the observation that PS-like, Tps/tb-dsRed2^+^ EpiSCs express low levels of neural markers ([Fig. 1C,E,F](#F1){ref-type="fig"}). Thus, undifferentiated EpiSCs are significantly heterogeneous and contain at least two major mutually exclusive subpopulations characterised by the expression of early PS and neural markers, respectively.

PS-like EpiSCs are self-renewing EpiSCs {#S4}
---------------------------------------

We next asked whether dsRed2^+^, PS and Sox1-GFP^+^, neural-like EpiSCs are capable of self-renewal. Like T(Bra)^+^ cells ([Fig. 1A](#F1){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S1) most dsRed2^+^ EpiSCs expressed the pluripotency markers Oct4, Nanog and Sox2 ([Fig. 2A](#F2){ref-type="fig"}). Moreover, they were positive for Cdh1, which marks early epithelia, including the postimplantation epiblast and endoderm. As T(bra) is not expressed in the endoderm ([@R13]), this suggests that Tps/tb-dsRed2 expression characterises pre-ingression, epiblast cells rather than committed, post-EMT mesoderm ([Fig. 2B](#F2){ref-type="fig"}). This suggests that PS-like EpiSCs are undifferentiated cells. We therefore tested whether dsRed2^+^ and dsRed2^-^ cells can self-renew. We flow sorted the two populations and re-plated them in EpiSC conditions. The resulting cultures arising from both dsRed2^+^ and dsRed2^-^ cells exhibited characteristic EpiSC colony morphology and Oct4 expression ([Fig. 2E](#F2){ref-type="fig"}). Moreover, daily fluorescence-activated cell sorting (FACS) analysis showed that by day 5 both sorted populations had re-equilibrated the routinely observed percentage of dsRed2^+^ cells (compare [Fig. 2C](#F2){ref-type="fig"} with [Fig. 1B](#F1){ref-type="fig"}). The two sorted populations expanded at a comparable rate, excluding the possibility of the apparent interconversion of dsRed^+^ and negative cells occurring by selective growth of one population over the other ([Fig. 2D](#F2){ref-type="fig"}). Thus, the PS-like EpiSC subpopulation exists in dynamic equilibrium with dsRed2^-^ cells, and both fractions exhibit features of undifferentiated EpiSCs.

![**PS-like Tps/tb-RED EpiSCs comprise a dynamic undifferentiated and self-renewing subpopulation.** (A) Oct4, Nanog and Sox2 immunocytochemistry. Right, image analysis of dsRed2 and indicated pluripotency markers (B) Cdh1 immunocytochemistry and dsRed2 fluorescence. (C) Flow cytometry-based timecourse analysis of dsRed2 expression in sorted and replated dsRed^+^ and dsRed^-^ populations in EpiSC conditions. (D) Numbers of sorted dsRed2^+^ and dsRed2^-^ cells post-sorting. (E) Oct4 immunocytochemistry and dsRed2 fluorescence at day 6 post-sorting of dsRed2^-^ cells. (F) Composition of colonies obtained after plating sorted dsRed2^+^ and dsRed2^-^ EpiSC at clonal density for 72 hours and immunohistochemistry for T(Bra) expression. Each bar in the *x*-axis represents a single clone. *y*-axis: number of T(Bra)^+^ (red) or T(Bra)^-^ (grey) cells/clone. Number of clones: N~dsRed+clones~=127, N~dsRed-clones~=136. Pie charts: overall percentages of cells of either phenotype (number of cells: N~dsRed+cells~=534, N~dsRed-cells~=584).](DEV101014F2){#F2}

To further verify the link between PS character and capacity for self-renewal, we sorted dsRed2^+^ and dsRed2^-^ cells, re-plated them at clonal density and examined by immunofluorescence the presence of T(Bra)^+^ cells in the resulting clones after culture in EpiSC conditions. Both populations generated clones containing T(Bra)^+^ cells although dsRed2^+^ derived clones contained a slightly higher proportion of T(Bra)^+^ cells ([Fig. 2F](#F2){ref-type="fig"}). Most clones comprised either T(Bra)^+^ or T(Bra)^-^ cells. However, some were heterogeneous, containing both T(Bra)^+^ and T(Bra)^-^ cells (24/127 from dsRed^+^ and 16/136 from dsRed^-^, of which a total of 20 contained ≤4 cells). This indicates that interconversion occurs not only between dsRed2 reporter positive and negative cells, but also between T(Bra)^+^ and T(Bra)^-^ states, which can interconvert within one to two divisions. ([Fig. 2F](#F2){ref-type="fig"}). These results additionally suggest that the PS characteristics we observed in EpiSCs do not compromise clonogenicity in culture conditions promoting an undifferentiated state.

We next examined whether neural-like Sox1-GFP^+^ EpiSCs also exhibit features of undifferentiated, self-renewing cells. In contrast to dsRed2^+^ cells, which were predominantly positive for the main three pluripotency factors, only about half of Sox1-GFP^+^ EpiSCs co-expressed Oct4 and Nanog, suggesting that the rest of the GFP^+^ cells had undergone neural commitment ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S4A). When sorted Sox1-GFP^+^ and negative cells were re-plated in EpiSC conditions, the two fractions showed a degree of interconversion, although the ability of Sox1-GFP^-^ EpiSCs to regenerate the GFP^+^ subpopulation was limited ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S4B). Taken together, the above data show that PS-like, Tps/tb-dsRed2^+^ EpiSCs exhibit hallmark features of bona fide undifferentiated EpiSCs such as expression of pluripotency factors and self-renewal ability. By contrast, Sox1-GFP^+^ neural-like EpiSC subpopulations are less dynamic and may contain cells committed to neural differentiation, consistent with the observation that *Sox1* mRNA levels are upregulated in EpiSC derivatives during neural differentiation ([@R39]).

Wnt signalling induces PS identity in undifferentiated EpiSCs {#S5}
-------------------------------------------------------------

Two candidate signals could, in theory, directly induce dsRed2 expression: Wnt and Activin/Nodal ([@R47]; [@R80]; [@R50]). As Activin is essential for EpiSC self-renewal and thus Activin/Nodal signalling should be active in both dsRed2- and dsRed2+ populations, we hypothesised that localised endogenous Wnt signalling drives dsRed2 expression. We observed that dsRed2+ EpiSCs were modestly enriched, and Sox1-GFP^+^ EpiSCs were slightly depleted, for the β-catenin target *Axin2* ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S5A). This suggests that PS-like EpiSCs experience higher levels of Wnt activity than their negative counterparts. We therefore tested whether Wnt signalling generates and/or maintains Tps/tb-RED EpiSCs.

Flow cytometry analysis showed that treatment of Tps/tb-RED EpiSCs with the Wnt ligand inhibitor Wif1 ([@R36]) significantly reduced the percentage of dsRed2^+^-expressing cells ([Fig. 3A](#F3){ref-type="fig"}). Wnt signalling attenuation resulting from the treatment was supported by a decrease in the mRNA levels of the Wnt targets *T*(*Bra*) and *Axin2* ([Fig. 3E](#F3){ref-type="fig"}), a reduction in the protein levels of T(Bra) ([Fig. 3B](#F3){ref-type="fig"}), and the expression of other early streak markers ([Fig. 3E](#F3){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S5B). Thus, Tps/tb-dsRed2 expression in undifferentiated EpiSCs depends on extracellular Wnt signalling. Interestingly, 5-day treatment with Wif1 had no obvious effect on either undifferentiated cell morphology (data not shown) or the expression of pluripotency factors *Oct4, Nanog* and *Sox2* ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S5B).

![**Wnt signalling confers PS characteristics upon EpiSCs.** (A) FACS analysis (upper row) and dsRed2 fluorescence (lower row) of dsRed2-expressing cells in untreated Tps/tb-RED EpiSC cultures and after treatment with Wif1 (120 hours) or CHIRON99021 (CHI) (48 hours) in Activin/Fgf2. (B) Immunocytochemistry of T(Bra) expression in control untreated, Wif1- and CHI-treated Tps/tb-RED EpiSCs. (C,D) T(Bra), Sox2 (C) and Oct4 (D) immunocytochemistry in fl/fl- and Δ/Δ-β-cat EpiSCs. Graphs: image analysis of T(Bra) and Sox2 immunofluorescence. (E) qPCR analysis of indicated markers in untreated, Wif1- (left) and CHI-treated (right) Tps/tb-RED EpiSCs. Expression is represented as log~10~ ratio versus untreated control. Error bars: s.d. (*n*=2) for +Wif1 and s.e.m. (*n*=3) for +CHI (*P*\<0.05 for all genes shown relative to untreated EpiSCs, Student's *t*-test). (F) qPCR analysis of indicated markers in fl/fl- and Δ/Δ-β-cat EpiSCs in self-renewing conditions and after 48 hours of CHI treatment. Expression is depicted as log~10~ ratio versus fl/fl EpiSCs (-CHI). Error bars: s.e.m. (*n*=3). N/D, not determined. ^\*^*P*\<0.05, compared with fl/fl- β-cat EpiSCs (-CHI). (G) Percentage of dsRed2-positive cells determined by flow cytometry after 48-hour inhibitor/cytokine treatment of Tps/tb-RED EpiSC. Error bars represent s.d. (*n*=2). (H) Immunocytochemistry of T(Bra), Sox2 and Foxa2 in CHI-treated EpiSC cultures. (I) Heatmap representing all differentially expressed genes (≥1.5-fold change) between sorted dsRed2 positive and negative fractions and CHI-treated EpiSCs. SB, SB431542; PD, PD0325901; Wnt, Wnt3a.](DEV101014F3){#F3}

To determine whether Tps/tb-dsRed2 expression was dependent on canonical \[β-catenin (*Ctnnb1*)-mediated\] Wnt signalling, we established an EpiSC line from floxed β-catenin ESCs (fl/fl-β-cat) ([@R11]) also carrying a CreER^T2^ cassette knocked into the ROSA26 locus ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S6A-C). 4-Hydroxytamoxifen-induced deletion of both floxed *Ctnnb1* alleles did not adversely affect the growth, self-renewal ([Fig. 3C](#F3){ref-type="fig"}) or Activin dependence ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S6D) of the resulting β-cat-null (Δ/Δ) EpiSC line, although β-cat Δ/Δ EpiSCs formed smaller colonies, possibly reflecting the role of *Ctnnb1* in cell adhesion ([@R53]). Thus Wnt/β-catenin signalling is not an essential mediator either of self-renewal or the Activin response. Consistent with the hypothesis that the effects of Wnt inhibition by Wif1 are primarily mediated through β-catenin, T(Bra) expression was completely ablated, and other PS markers strongly downregulated, in *Ctnnb1* null EpiSCs ([Fig. 3C,F](#F3){ref-type="fig"}). By contrast, control fl/fl-β-cat EpiSCs, like Tps/tb-RED EpiSCs, exhibited heterogeneous T(Bra) expression ([Fig. 3C,F](#F3){ref-type="fig"}). However, probably because of the more severe effects of deleting a unique effector of Wnt signalling compared with addition of an inhibitor protein, β-cat Δ/Δ EpiSCs also exhibited a striking upregulation of *Sox2, Otx2* and, to a lesser extent, *Six3*, which are expressed by the anterior epiblast undergoing neural specification ([@R39]; [@R1]; [@R14]) ([Fig. 3C,F](#F3){ref-type="fig"}). By contrast, levels of the pluripotency factors *Oct4* and *Nanog* were unchanged ([Fig. 3D,F](#F3){ref-type="fig"}). Collectively, the above results indicate that Wnt/β-catenin signalling is pivotal for inducing the PS-like EpiSC state at the expense of an anterior epiblast-like fraction, but is dispensable for EpiSC maintenance.

Elevation of Wnt signalling activity promotes distinct precursor-like populations {#S6}
---------------------------------------------------------------------------------

We next assessed the effects of elevating Wnt signalling levels in EpiSCs. Short-term treatment of EpiSCs with CHIRON99021 (CHI), a potent Gsk-3 (Gsk3b - Mouse Genome Informatics) inhibitor that stabilises β-catenin and activates Wnt targets ([@R63]; [@R58]), in EpiSC conditions greatly enhanced both dsRed2 and T(Bra) protein expression ([Fig. 3A,B,E](#F3){ref-type="fig"}). Treatment of cultures with recombinant Wnt3a protein also led to a more modest increase in the number of Tps/tb-dsRed2^+^ cells ([Fig. 3G](#F3){ref-type="fig"}). Interestingly, the Alk4/5/7 (Acvr1b/Tfgbr1/Acvr1c - Mouse Genome Informatics) Activin/Nodal receptor inhibitor SB431542 (SB43) ([@R38]) negated the CHI or Wnt3a-driven increase in dsRed2^+^ cell numbers, whereas MEK inhibition with PD0325901 had a less prominent effect ([Fig. 3G](#F3){ref-type="fig"}). This suggests that full Wnt stimulation of Tps/tb promoter transcription requires active Nodal/Activin signalling.

The increase in Tps/tb-dsRed2 expression after CHI treatment of EpiSC cultures was accompanied by a significant upregulation of both Wnt-responsive genes and other PS-specific markers ([Fig. 3E](#F3){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S5B) as well as a decrease in the expression of pluripotency factors ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S5C). Interestingly, although CHI treatment of *Ctnnb1*-null EpiSCs did not alter their undifferentiated, anterior epiblast-like phenotype, it induced a small but significant (*P*\<0.05, Student's *t*-test) upregulation of *T*(*Bra*) and *Mesp1* relative to untreated Ctnnb1-null cells ([Fig. 3F](#F3){ref-type="fig"}). This indicates that the control of PS identity is not exclusively β-catenin-dependent. Furthermore, CHI treatment of Sox1-GFP EpiSCs considerably reduced the GFP-expressing fraction ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S5D). Interestingly, the remaining Sox2^+^ cells that persisted in the CHI-treated cultures were predominantly T(Bra)^+^ ([Fig. 3H](#F3){ref-type="fig"}). These T(Bra)^+^Sox2^+^ cells were generally mutually exclusive to a Foxa2^+^ fraction, part of which also co-expressed T(Bra) ([Fig. 3H](#F3){ref-type="fig"}). This suggests that Wnt stimulation promotes the generation of both T(Bra)^+^Foxa2^+^ and T(Bra)^+^Sox2^+^ cells. Double positivity for T(Bra) and Foxa2 has been linked to a common ME precursor ([@R46]; [@R27]). Furthermore, in several vertebrates, T(Bra)/Sox2 co-expression marks a region containing NM axial progenitors ([@R55]; [@R59]). We previously showed that, in the early somite stage mouse embryo, NM progenitors reside in the node-streak border (NSB) and the region lateral to the PS ([@R15]). We confirmed that cells in this region also co-expressed T(Bra) and Sox2 in the mouse ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S7). Thus CHI treatment of EpiSCs mediates the production of two mutually exclusive populations exhibiting features of distinct progenitors: ME precursors marked by T(Bra)/Foxa2 co-expression and T(Bra)^+^Sox2^+^ NM progenitors.

Microarray expression profiling of CHI-treated EpiSCs showed that elevation of Wnt signalling induced dramatic global changes in the EpiSC transcriptome (2815 differentially expressed genes based on a 1.5-fold change threshold with FDR ≤0.05) ([Fig. 3I](#F3){ref-type="fig"}). Inspection of the reported expression patterns of the most upregulated transcripts confirmed that CHI treatment significantly induced genes representative of PS-derived lineages and Wnt-related transcripts ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Table S1). We also noted upregulation of Hox transcripts predominantly belonging to paralogous groups 5-9, which are activated during late gastrulation (reviewed in [@R23]) ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S5E). By contrast, two of the most downregulated genes after CHI treatment were the pluripotency factors *Oct4* and *Nanog* ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Table S1). Interestingly, CHI addition also considerably reduced the levels of anterior neural markers such as *Pou3f1* and *Zic2* ([@R39]) ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Table S1; data not shown) while posterior neural plate-specific transcripts such as *Zic3* and *Gbx2* ([@R39]) were upregulated ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Table S1; data not shown). Collectively, the above findings indicate that CHI-mediated elevation of Wnt activity promotes exit from pluripotency, suppresses anterior neural cell fate and drives PS-like cell differentiation towards derivatives produced *in vivo* by distinct ME and NM precursor populations.

PS-like EpiSCs exhibit increased mesendodermal differentiation *in vitro* {#S7}
-------------------------------------------------------------------------

Regionalised expression of T(Bra) and Wnt3 within the postimplantation embryo has been shown to precede the differentiation of pluripotent epiblast cells to PS-associated lineages ([@R64]; [@R13]). We therefore tested whether the Wnt-dependent dsRed^+^ PS-like cells are functionally distinct from their dsRed^-^ counterparts. We first tested the ability of the dsRed2^+^ and dsRed2^-^ populations to generate distinct lineage derivatives using embryoid body-like aggregate (EB) formation ([@R75]). We FACS-sorted dsRed2^+^ and dsRed2^-^ EpiSCs and, after generating EBs from each fraction, we quantified the emergence of beating cardiomyocytes during differentiation ([Fig. 4A](#F4){ref-type="fig"}). EBs derived from the PS-like EpiSC fraction contained a higher proportion of both beating foci and cells positive for the early cardiac transcription factor Nkx2-5 ([@R68]) than dsRed2^-^-derived EBs ([Fig. 4A,B](#F4){ref-type="fig"}).

![**Tps/tb promoter activity in EpiSCs correlates with distinct differentiation choices *in vitro***. (A) Cardiomyocyte differentiation expressed as percentage of beating foci/total plated EBs at different time points after sorting dsRed2^+^ and dsRed2^-^ EpiSCs. Unsorted EBs are included as a control. Error bars represent s.e.m. (*n*=3). ^\*^*P*\<0.05 (Student's *t*-test). (B) Immunocytochemistry of Nkx2-5 expression in plated EBs derived from sorted dsRed2^+^ and dsRed2^-^ EpiSC fractions. (C) qPCR analysis of paraxial mesoderm and cardiac/endoderm marker expression in sorted dsRed2^+^ and dsRed2^-^ EpiSC-derived EBs. Values are expressed relative to undifferentiated EpiSCs. Error bars: s.e.m. (*n*=3). ^\*^*P*\<0.05 (Student's *t*-test). (D) T(Bra) and Foxa2 immunofluorescence in colonies obtained after plating sorted Tps/tb-RED EpiSCs at clonal density for 48 hours in the presence of CHI. (E) Composition of colonies obtained after plating sorted dsRed2^+^ and dsRed2^-^ EpiSC at clonal density for 48 hours in CHI, depicted as in [Fig. 2F](#F2){ref-type="fig"}. Number of clones: N~dsRed+clones~=126, N~dsRed-clones~=130. Pie charts: overall percentages of cells of each phenotype (number of cells: N~dsRed+cells~=409, N~dsRed-cells~=385). (F) Proportions of T(Bra)+ cells in steady-state dsRed2^+^ and dsRed2^-^ EpiSC populations (data from [Fig. 1D](#F1){ref-type="fig"}) and after sorting and plating in EpiSC (data from [Fig. 2F](#F2){ref-type="fig"}) or CHI treatment conditions (data from Fig. 4E). C, control.](DEV101014F4){#F4}

We also assessed the induction of cardiac (*Mesp1*), cardiac/gut endoderm (*Gata4, Gata6*) ([@R57]; [@R65]) and paraxial/somitic mesoderm (*Meox1, Hoxb1, Tbx6*) ([@R16]; [@R19]; [@R26]) markers by qPCR in EBs differentiated for 3 days after sorting dsRed2^+^ and dsRed2^-^ EpiSCs. We found that expression of several of these markers was significantly enriched in dsRed2^+^-derived EBs versus those from dsRed2^-^ cells ([Fig. 4C](#F4){ref-type="fig"}). By contrast, we did not observe any significant differences in the induction of endoderm-specific transcripts such as *Gsc, Sox17* and *Hex* (*Hhex* - Mouse Genome Informatics) within the same day 3 EBs between the two populations ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S8A). Moreover, in neural inducing conditions ([@R31]), sorted dsRed2^+^ and dsRed2^-^ cells did not exhibit significant differences in their ability to upregulate the neural markers *Sox1* and *Sox2* ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S8B). Thus dsRed2^+^ cells show a strong bias towards mesodermal differentiation. However, consistent with the hypothesis that these cells are pluripotent EpiSCs, dsRed2^+^ cells are still capable of generating endodermal and neural derivatives.

We next sought to define the potency of single dsRed2^+^ and dsRed2^-^ cells during CHI-mediated differentiation. Flow-sorted dsRed2^+^ and negative EpiSCs were plated at clonal density in the presence of CHI, Activin A and Fgf2 and the induction of mesoderm and endoderm was assessed by scoring T(Bra)^+^ and Foxa2^+^ cells in the resulting colonies ([Fig. 4D](#F4){ref-type="fig"}). After 48 hours' culture the majority of cells derived from both populations expressed T(Bra) protein to a similar extent (67% in dsRed2^+^-derived cells versus 63% in dsRed2^-^-derived cells) ([Fig. 4E](#F4){ref-type="fig"}). Taken together with clonal data obtained in EpiSC conditions ([Fig. 2F](#F2){ref-type="fig"}) and measurement of the starting proportions of T(Bra)^+^ cells ([Fig. 1D](#F1){ref-type="fig"}), these data indicate that cells plated at clonal density respond in a similar manner to the whole population ([Fig. 2C](#F2){ref-type="fig"}, [Fig. 3A](#F3){ref-type="fig"}) by re-equilibrating the proportions of T(Bra)^+^ cells in EpiSC conditions, and dramatically increasing T(Bra)^+^ cell numbers in +CHI conditions ([Fig. 4F](#F4){ref-type="fig"}). In theory, these responses could have occurred by *de novo* induction of T(Bra), or by selection of pre-existing populations. The high frequency of heterogeneous clones (25% of both dsRed2^+^ and dsRed2^-^ clones), showing that individual cells could switch phenotypes, together with the similar numbers of clones, indicating that no condition selected against the majority of cells, and the even distribution of T(Bra)^+^ and T(Bra)^-^ clone sizes, arguing against differential growth rates, all support the hypothesis that these populations are predominantly induced rather than arising by selection. However, live tracking of individual cells would be required to unequivocally distinguish these two possibilities.

dsRed2^+^ cells generated significantly more double T(Bra)^+^Foxa2^+^ cells (43% from dsRed2^+^ versus 27% from dsRed2^-^, χ^2^, *P*\<0.01), whereas dsRed2^-^ cells tended to generate T(Bra)^+^ single positive cells (36% from dsRed2^-^ versus 24% from dsRed2^+^, χ^2^, *P*\<0.01; [Fig. 4E](#F4){ref-type="fig"}). Most clones were homogeneous for these markers, but some (notably clones consisting of four or more cells) contained both T(Bra) and Foxa2 single positive cells ([Fig. 4E](#F4){ref-type="fig"}), showing that a single cell can generate both T(Bra)^+^ putative mesoderm and Foxa2^+^ putative endoderm, especially after two or more divisions. Together, these findings suggest that upon Wnt activation, PS-like EpiSCs favour the production of mesendoderm-like T(Bra)^+^Foxa2^+^ cells, whereas the dsRed2^-^ population preferentially generates T(Bra)^+^ putative mesoderm.

Differentiation bias of PS-like EpiSCs *in vivo* {#S8}
------------------------------------------------

We have recently shown that mouse EpiSCs can be grafted into cultured gastrula stage embryos where they adopt cell identities instructed by their host environment in accordance with published fate maps ([@R37]). Thus, embryo grafting provides a stringent assay for testing how distinct cell populations respond to region-specific differentiation-inducing signals. To assess whether the *in vitro* lineage bias of PS-like EpiSCs is also evident *in vivo*, Tps/tb-RED EpiSCs constitutively expressing GFP (a line termed C2) ([@R37]) were FACS-sorted into dsRed2^+^GFP^+^ and dsRed2^-^GFP^+^ populations and grafted into two distinct sites of mid-to-late streak stage embryos, the anterior/distal part of the PS (ANT), which produces derivatives of all three germ layers, and the mid PS (MP), which principally gives rise to mesoderm and endoderm ([Fig. 5A](#F5){ref-type="fig"}) (reviewed by [@R73]). The recipient embryos were cultured for 24-48 hours and the incorporation of the two sorted fractions was assessed by fluorescence microscopy after sectioning ([Fig. 5A](#F5){ref-type="fig"}). Most embryos developed normally (51/54, 94%) and contained GFP^+^ cells after culture (50/51, 98%; [Fig. 5C](#F5){ref-type="fig"}).

![**Tps/tb promoter activity in EpiSCs correlates with distinct differentiation choices *in vivo***. (A) Diagram showing graft sites in mid-late streak embryo (mid-posterior, MP; and anterior streak, Ant). (B) Extent of incorporation (percentage of sections containing donor cells/total sections) after grafting sorted dsRed2^+^GFP^+^, dsRed2^-^GFP^+^ or unsorted GFP^+^ EpiSCs into the indicated sites. *P*-values were calculated using the χ^2^ test. For Ant grafts: N~dsRed+~=4, N~dsRed-~=5, N~unsorted~=2). For MP grafts: N~dsRed+~=4, N~dsRed-~=4, N~unsorted~=4). ^\*^*P*\<0.05; ^\*\*^*P*\<0.01 (chi-squared test). See [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Table S2 for individual embryo data. (C) Representative examples of M-LS embryo grafts (0 hours) and distribution of sorted dsRed2^+^GFP^+^ and dsRed2^-^GFP^+^ EpiSCs after 24 hours embryo culture. Arrowheads, graft sites. Asterisk, clump in amniotic cavity. (D) Representative examples of donor cell incorporation (green, GFP) and differentiation (red, immunofluorescence for indicated markers). Grey, 4′,6-diamidino-2-phenylindole (DAPI) counterstain. Arrowheads, co-expressing donor cells. Note: dsRed2 expression was undetectable after 48-hour culture in the absence of doxycycline. (E) Extent of incorporation after grafting of CHI-treated GFP^+^ EpiSCs into the anterior PS of M-LS stage embryos. Note: untreated control frequencies reproduced from B (^\*^*P*\<0.01; N~+CHI~=4, N~unsorted~=2). (F,G) Grafting of C2 EpiSCs ±CHI treatment to E8.5 embryos and culture for 24-48 hours. (F) Left, representative embryos and right, donor cell contribution. (G) Green, GFP immunofluorescence; red, indicated marker immunofluorescence in representative sections after culture; blue or grey, DAPI counterstain. Note that the images depicting NP and PXM contribution belong to the same embryo. Arrowheads, co-expressing donor cell. AL, allantois; Ant, anterior streak; AXM, axial mesoderm; DA, dorsal aorta; EN, endoderm; MP, mid posterior; NON-INT, non-integrated cell clumps; NP, neural plate; PXM/LM, paraxial/lateral mesoderm; PS, primitive streak; V/LM, ventral/lateral mesoderm.](DEV101014F5){#F5}

To compare the distribution of the grafted cell populations, we sectioned a subset (25/51) of the cultured embryos and scored GFP^+^ cells in embryonic tissues, confirming correct differentiation using antibodies to T(Bra), Sox2 and Foxa2 ([Fig. 5D](#F5){ref-type="fig"}). As reported previously for unsorted EpiSCs ([@R37]), both sorted fractions exhibited patterns of integration and differentiation consistent with published fate maps following engraftment ([Fig. 5B](#F5){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Table S2). However, we also observed striking differences. dsRed2^+^ cells showed a statistically significant, enhanced endodermal and axial mesodermal contribution ([Fig. 5B](#F5){ref-type="fig"}) in either MP or both graft types, consistent with the close lineal relationship between axial mesoderm and endoderm progenitors *in vivo* ([@R43]) ([Fig. 5B](#F5){ref-type="fig"}). Conversely, dsRed2^-^ cells colonised the PS and formed non-integrated clumps more frequently than dsRed2^+^ cells following grafting into either region ([Fig. 5B](#F5){ref-type="fig"}), suggesting that the integration of dsRed2^-^ cells in the PS is impaired, leading to a delayed exit from this site ([Fig. 5B](#F5){ref-type="fig"}). Despite their difference in endoderm and axial mesoderm contribution, both fractions appeared to incorporate to paraxial and lateral mesodermal tissues at a similar frequency ([Fig. 5B](#F5){ref-type="fig"}). dsRed2^-^ EpiSCs also showed marginally higher colonisation of the neural plate (NP) in either MP or ANT locations. Together these data indicate that the PS-like, dsRed2^+^ EpiSC fraction is significantly biased towards PS derivatives *in vivo* ([Fig. 5B](#F5){ref-type="fig"}). However, similar to the *in vitro* data, dsRed2^+^ cells have not lost the ability to contribute to neurectoderm, consistent with a pluripotent status.

Wnt signalling stimulation in EpiSCs promotes ME and NM lineage restriction *in vivo* {#S9}
-------------------------------------------------------------------------------------

We next examined whether the ME-like and NM-like populations induced by CHI treatment can produce functional cell types *in vivo*. C2 EpiSCs were treated with CHI for 48 hours and then grafted into the ANT region of mid-late streak embryos ([Fig. 5A](#F5){ref-type="fig"}). Cultured host embryos were then analysed as above. Interestingly, we observed exclusive contribution of the donor cells to mesoderm and endoderm and complete absence of grafted cells from the neural plate ([Fig. 5E](#F5){ref-type="fig"}). This finding implies that, in line with our *in vitro* data, elevated Wnt signalling abolishes EpiSC pluripotency, restricting differentiation, in the context of the gastrulation stage embryo, to mesoderm and endoderm fates. Moreover, paraxial and lateral mesoderm contribution was highly enriched in CHI-treated EpiSCs and axial mesoderm was not colonised at all ([Fig. 5E](#F5){ref-type="fig"}), suggesting that high Wnt activity restricts the developmental potential of mesoderm progenitors.

The upregulation of somitogenesis stage markers in CHI-treated cultures (e.g. Hox paralogous groups 5-9; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S5E) prompted us to examine whether Wnt-stimulated EpiSC cultures include late PS progenitors. We have shown that EpiSCs fail to integrate into the NM progenitor-containing NSB of embryos that have initiated somitogenesis ([@R37]). Strikingly, CHI-treated C2 EpiSC integrated extensively into older embryos following engraftment into the E8.5 NSB in contrast to untreated EpiSCs ([Fig. 5F](#F5){ref-type="fig"}). They colonised all embryos (6/6) analysed following culture while only one of four embryos grafted with untreated EpiSC exhibited minimal chimerism ([Fig. 5F](#F5){ref-type="fig"}; data not shown). Importantly, the grafted CHI-treated cells differentiated predominantly into Pax3-positive somitic/paraxial mesoderm ([@R30]), Snai2-positive lateral/ventral mesoderm ([@R69]) and Pecam1-positive endothelia ([@R4]) ([Fig. 5G](#F5){ref-type="fig"}). Moreover, in two recipient embryos, we detected GFP^+^ cells in both the neural tube and somites, suggesting that CHI treatment can induce cells with neuromesodermal potency ([Fig. 5G](#F5){ref-type="fig"}). Collectively, these findings show that Wnt signalling elevation drives differentiation of cells into mesoderm and endoderm lineages compatible with gastrulation stage embryos, and mesoderm and neural lineages compatible with somitogenesis stage embryos. This raises the possibility that the T(Bra)^+^Foxa2^+^ and T(Bra)^+^Sox2^+^ cells induced by CHI treatment are ME and NM progenitors, respectively.

DISCUSSION {#S10}
==========

Acquisition of lineage identity within primed pluripotency {#S11}
----------------------------------------------------------

Heterogeneity is prevalent in mouse and human pluripotent cell populations ([@R18]; [@R17]; [@R10]; [@R22]) but few studies have focused on EpiSCs, and these have defined only minor (0.5-1.5%) functionally distinct subpopulations ([@R35]; [@R34]). Here, we reveal the existence of two major EpiSC subpopulations, each representing up to 30% of the total EpiSC population, relevant to the gastrulating embryo: PS- and neural-like cells ([Fig. 6](#F6){ref-type="fig"}). This plasticity in undifferentiated EpiSCs is reminiscent of the situation in the gastrula stage embryo, where the principal postimplantation pluripotency determinant Oct4 ([@R60]) is expressed within cells that upregulate markers characteristic of the lineage(s) they are fated to generate ([@R74]; [@R14]; [@R60]). Teratocarcinoma formation and heterotopic grafting experiments indicate that although cell fate during gastrulation is regionalised, epiblast cells remain pluripotent until the beginning of somitogenesis ([@R5]; [@R6]; [@R7]; [@R60]). Our observation of lineage-biased EpiSC subpopulations suggests that regionalised epiblast populations have begun the process of lineage specification, but that these PS-like or neural-like states are initially reversible. In EpiSCs, these events do not lead to lineage commitment, probably because of the constraints imposed upon the cells by the pluripotency-promoting culture conditions, raising the possibility that similar constraints may act upon the gastrulation stage epiblast.

![**Model of PS precursor specification *in vitro***. Undifferentiated EpiSC cultures contain two major mutually exclusive subpopulations: a Wnt/β-catenin-low partially committed neural-like and a PS-biased pluripotent, reversible fraction marked by slightly higher Wnt levels. Further elevation of Wnt/β-catenin signalling above this pluripotency-compatible Wnt activity threshold promotes the generation of lineage-restricted populations resembling mesendodermal (ME) and neuromesodermal (NM) precursors. Red arrows, Wnt effects.](DEV101014F6){#F6}

Wnt signalling as a driver of plastic PS-like identity in undifferentiated EpiSC {#S12}
--------------------------------------------------------------------------------

*In vivo*, Wnt/β-catenin signalling has been implicated in the initiation of PS formation ([@R52]; [@R40]; [@R56]) and the establishment, in collaboration with T(Bra), of a 'mesodermal progenitor niche' in zebrafish ([@R54]). Our data showing that Wnt/β-catenin signalling promotes a PS-like population *in vitro* are in line with these findings as well as a number of other studies demonstrating that Wnt/β-catenin drives PS-like differentiation *in vitro* ([@R25]; [@R10]; [@R71]; [@R41]). However, our study distinguishes two separate roles of Wnt/β-catenin signalling. Low Wnt activity in self-renewing EpiSCs is sufficient to impose a reversible, pluripotent, early PS character; elevation of Wnt signalling levels above this pluripotency-permissive threshold via CHI treatment drives commitment to mesodermal/endodermal and posterior neural/mesodermal fates ([Fig. 6](#F6){ref-type="fig"}). We also provide evidence that Wnt/β-catenin signalling represses anterior epiblast/early neural features ([Fig. 6](#F6){ref-type="fig"}, [Fig. 3F](#F3){ref-type="fig"}). A recent study examining multiple EpiSC lines has revealed that a Wnt signalling gene expression signature characterises the EpiSC transcriptome, potentially contributing to the acquisition of a PS character ([@R45]). Interestingly, self-renewing EpiSCs are also marked by the activity of a pro-anterior neural plate transcriptional network that includes Otx2 and Sox2, stabilising an undifferentiated EpiSC state by repressing mesodermal/endodermal differentiation ([@R39]). Our data integrate these findings, showing that early anterior neural and PS-like subpopulations coexist within self-renewing EpiSC cultures and that Wnt/β-catenin activity limits the former while stimulating the latter ([Fig. 6](#F6){ref-type="fig"}, [Fig. 3F](#F3){ref-type="fig"}).

High levels of Wnt signalling generate two distinct PS-derived precursor populations {#S13}
------------------------------------------------------------------------------------

T(Bra)^+^Foxa2^+^ ME precursors that can generate cardiac mesoderm and endoderm have been previously described in Wnt-induced ESC differentiation ([@R46]; [@R27]). Our data show that similar cells are frequent in PS-like dsRed2^+^ EpiSCs ([Fig. 1D](#F1){ref-type="fig"}). The preferential contribution of sorted dsRed2^+^ EpiSCs to endoderm *in vivo* ([Fig. 5B](#F5){ref-type="fig"}) and the increased frequency of T(Bra)^+^Foxa2^+^ cells from single dsRed2^+^ cells in the presence of CHI ([Fig. 4E](#F4){ref-type="fig"}) also suggest that the acquisition of PS characteristics by undifferentiated EpiSCs is the earliest 'entry point' of commitment to an ME precursor state. Thus in the embryonic PS, ME-like dsRed2^+^ cells may integrate and exit from this region more efficiently than dsRed2^-^ cells, and as a consequence favour endoderm, an early PS derivative. Conversely, CHI treatment of dsRed2^-^ cells, which favours production of T(Bra)^+^ putative mesoderm over T(Bra)^+^Foxa2^+^ ME cells, offers an explanation for the discrepancy between *in vitro* data showing that in EB differentiation dsRed2^-^ cells are biased against mesoderm differentiation, whereas they efficiently produce mesoderm *in vivo*. The PS, a natural source of Wnt signals, may induce mesoderm in preference to endoderm in dsRed2^-^ cells. Furthermore, the increased paraxial mesoderm differentiation *in vivo* exhibited by CHI-treated cells ([Fig. 5E](#F5){ref-type="fig"}) probably results from its induction of T(Bra)^+^ mesoderm precursors from dsRed2^-^ cells, as these constitute the majority of steady-state Tps/tb-RED EpiSC cultures.

Co-expression of T(Bra) and Sox2 marks NM progenitors in various vertebrates ([@R55]; [@R59]) and our data confirm this in the mouse ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S7). We also demonstrate that elevated Wnt signalling leads to the generation of T(Bra)^+^Sox2^+^ cells *in vitro* that are distinct from T(Bra)^+^Foxa2^+^ putative ME progenitors. The specific upregulation of posterior but not anterior neurectodermal markers, the induction of trunk Hox genes and the neuromesodermal contribution of CHI-treated EpiSCs after engraftment into the NSB of some embryos support the hypothesis that Wnt-driven T/Sox2 co-expression also marks NM-potent cells *in vitro*. The generation of the two mutually exclusive (Bra)^+^Foxa2^+^ (ME-like) and T(Bra)^+^Sox2^+^ (NM-like) entities upon EpiSC differentiation is in agreement with retrospective clonal analysis data from the mouse embryo showing that early-ingressing mesodermal types such as cardiac mesoderm can arise from a common ME precursor while the later-ingressing paraxial mesoderm is produced by a common NM progenitor ([@R76]). Our data underline the similarity between EpiSCs and the gastrulation stage epiblast, implying that EpiSCs can be used as a physiologically relevant system to study events during gastrulation *in vitro*.

MATERIALS AND METHODS {#S14}
=====================

Cell culture and differentiation {#S15}
--------------------------------

Feeder-free EpiSCs were derived from ESCs ([@R33]) or embryonic day (E) 6.5 embryos ([@R60]) and maintained as described previously ([@R60]). Tps/tb-RED EpiSCs were generated from an ESC line containing a randomly integrated PS- and tail bud-specific 1.2 kb *T*(*Bra*) promoter fragment ([@R20]) driving the reverse tetracycline transactivator rtTA2^S^-M2 and a tet-responsive element-linked dsRed2 transgene knocked into the *hprt* locus. The parental ESC line (C.E., A.T. and V.W., unpublished) will be described in detail elsewhere. dsRed2 expression was induced and maintained by continuous culture in doxycycline (1 μg/ml; Sigma). *Ctnnb1* null EpiSCs were established after 4-hydroxytamoxifen treatment following differentiation from ESCs derived from a mouse line containing two floxed *Ctnnb1* alleles, a floxed phosphoglycerate kinase-GFP (Pgk-GFP) cassette and the Cre-ER^T2^ transgene knocked into the ROSA26 locus ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.101014/-/DC1) Fig. S6) ([@R11]; [@R29]). For cardiomyocyte differentiation ∼10^6^ cells were cultured in suspension in Glasgow minimum essential medium (GMEM) + 10% fetal calf serum for 4 days followed by transfer of EBs to gelatinised wells of 24-well plates (5-10 EBs/well). For inhibition and neural differentiation experiments, cells were plated in the presence of the MEK-Erk inhibitor PD0325901 (1 μM; Signal Transduction Division, Dundee, UK) and the Tgfβ/Nodal inhibitor SB431542 (10 μM; Sigma) (∼350,000/well in 6-well plates) for 48-72 hours. To inhibit Wnt signalling, EpiSC cultures were treated for 5 days with recombinant human Wif1 (0.8 μg/ml, R&D Systems) with daily media changes. To stimulate Wnt signalling, cells cultured on fibronectin-coated wells (Sigma) were treated for 48-72 hours with CHIRON99021 (3 μM, Signal Transduction Division, Dundee) or Wnt3a (50 ng/ml, R&D Systems). For clonal density experiments, cells were plated at 10,000 cells/well in 6-well plates. Using a 1:1 mixture of GFP^+^ and GFP^-^ cells we confirmed that, at this density, 95% of the resulting colonies consisting of two to eight cells are of monoclonal origin.

Embryo grafting and scoring {#S16}
---------------------------

Embryo grafting, culture and imaging was performed as described ([@R37]) using either 48-hour CHI-treated or flow-sorted EpiSCs, the latter plated overnight in four-well dishes in standard EpiSC conditions, to allow coherent cell clumps to form.

RNA analysis and microarrays {#S17}
----------------------------

RNA isolation, cDNA synthesis and real-time qPCR expression analysis were performed as described previously ([@R60]). Each biological replicate in qPCR experiments comprised three technical replicates. For microarrays, total RNA from three biological replicates was isolated and labelled/amplified using the Illumina TotalPrep RNA Amplification Kit (Life Technologies). Whole genome expression profiling was performed using Illumina MouseWG-6 v2 arrays (Edinburgh Wellcome Trust Clinical Research Facility). Microarray analysis was performed in the R statistical environment using the lumi package ([@R24]). Data pre-processing was performed using background subtraction, variance stabilising transformation (VST) and robust spline normalisation (RSN). Differentially expressed genes were identified using the limma package with fold-change (FC) ≥1.5 and FDR ≤0.05 ([@R70]). The raw data have been deposited in GEO with accession number GSE48476.

Immunocytochemistry {#S18}
-------------------

Immunocytochemistry was performed as described previously ([@R60]). Primary antibody concentrations were: anti-Nanog, 2.5 μg/ml (14-5761-80, eBioscience); anti-Oct4, 1 μg/ml (N-19, Santa Cruz); anti-Sox2, 0.5 μg/ml (Y-17, Santa Cruz) or 1:200 (ab92494, Abcam); anti-Foxa2, 2 μg/ml (M-20, Santa Cruz) or 1:200 (ab40874, Abcam); anti-Gsc 2 μg/ml (N-12, Santa Cruz); anti-T (Bra), 1 μg/ml (AF2085, R&D); anti-Cdh1, 0.4 μg/ml (ECCD2, Calbiochem); anti-Cdh2, 5 μg/ml (8C11, BD Biosciences); anti-Nes, 1:20 (Rat-401, DSHB); anti-Nkx2.5, 20 μg/ml (ab35842, Abcam); anti-CD31, 4 μg/ml (MEC 13.3, BD Pharmingen).

Imaging and image analysis {#S19}
--------------------------

Fluorescence in cultured cells was visualised using an Olympus IX51 inverted microscope (Olympus) or an inverted Confocal Leica TCS SPE microscope after culture on fibronectin-coated glass coverslips. Whole embryos were imaged using a Nikon NZ100 dissecting microscope, and sections were imaged in an Olympus BX61 fluorescence compound microscope. Images were captured using Volocity software (PerkinElmer). Nuclear segmentation followed by single cell fluorescence quantification was performed as described previously ([@R60]).

Flow cytometry {#S20}
--------------

Flow cytometry analysis was performed using a FACSCalibur (BD Biosciences) cytometer. Cell sorting was performed using a FACSAria (BD Biosciences). For interconversion and clonal plating experiments, cells were treated for 30 minutes with the ROCK inhibitor Y-27632 (10 μM; Calbiochem) before dispersal and for 24 hours after sorting.
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